Globus Medical (GMED)
NYSE · Healthcare · Medical Devices
Globus Medical is a Healthcare company with a market capitalization of $11.71B and a trailing P/E ratio of 20.2.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 7, 2026 | $1.12 | $0.92 | +21.7% |
| Q4 2025 | February 24, 2026 | $1.28 | $1.15 | +11.0% |
| Q3 2025 | November 6, 2025 | $1.18 | $0.78 | +51.3% |
| Q2 2025 | August 7, 2025 | $0.86 | $0.75 | +14.7% |
| Q1 2025 | May 8, 2025 | $0.68 | $0.75 | -9.3% |
| Q4 2024 | February 20, 2025 | $0.84 | $0.75 | +12.2% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Globus Medical's market cap?
As of June 29, 2026, Globus Medical (GMED) has a market capitalization of $11.71B.
What is Globus Medical's P/E ratio?
Globus Medical trades at a trailing price-to-earnings (P/E) ratio of 20.2. Its forward P/E is 19.0.
Does Globus Medical pay a dividend?
Globus Medical does not currently pay a dividend.
What sector is GMED in?
Globus Medical is in the Healthcare sector, specifically the Medical Devices industry.
What was Globus Medical's revenue?
In its latest reported fiscal year (ending December 31, 2025), Globus Medical reported revenue of $2.94B and net income of $537.90M.
Ask your own questions about GMED
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.